7,654.75

+40.75

+0.54%

52,199.00

+281.00

+0.54%

28,797.50

+263.50

+0.92%

Russell 2000 Futures

2,845.70

+24.40

+0.86%

4.9290

-0.0600

-1.20%

18.82

-0.60

-3.09%

3,906.80

+7.90

+0.20%

77,888.73

+0.63

+0.00%

Crude Oil Dec 26

99.60

-4.52

-4.34%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

KALA BIO, Inc. (KALA)

0.1655 -0.0096 (-5.48%)

At close: October 30 at 4:00:00 PM EDT

0.1655 0.0000 (0.00%)

Pre-Market: 4:31:16 AM EST

Loading Chart for KALA

Chart Range Bar

Interval:

In partnership with ChartIQ

KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team

KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team

Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests

Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership

Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

KALA BIO Announces Reverse Stock Split

KALA BIO Announces Reverse Stock Split

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

BC-Most Active Stocks

BC-Most Active Stocks

KALA BIO: Q3 Earnings Snapshot

KALA BIO: Q3 Earnings Snapshot

Mobilize your Website

View Site in Mobile | Classic

Share by: